HK Stock Market Move | DUALITYBIO-B(09606) rose over 4% in early trading, ADAM9-targeted ADC cancer new drug approved for clinical trials in China.
Ying En Biology-B (09606) rose more than 4% in the morning session, as of the time of writing, it is up 2.42% to HK$363.6, with a trading volume of HK$51.05 million.
DUALITYBIO-B (09606) rose over 4% in the morning session, as of the time of writing, it is up by 2.42% and is trading at 363.6 Hong Kong dollars with a turnover of 51.05 million Hong Kong dollars.
On the news front, on January 19th, Ennogen announced that its independently developed ADAM9 targeted antibody-drug conjugate (ADC) DB-1317 has obtained approval for new drug clinical trials from the drug evaluation center of the National Medical Products Administration (CDE), allowing for its use as a single agent in clinical trials for advanced/metastatic solid tumor patients.
It is reported that DB-1317 is a new generation ADC product developed based on Ennogen's proprietary ADC technology platform DITAC, with global rights. Its target ADAM9 is highly expressed in various tumors such as gastric cancer, colorectal cancer, pancreatic cancer, non-small cell lung cancer, but has low expression levels in normal tissues. Preclinical studies have shown that DB-1317 exhibits significant anti-tumor activity in various tumor models.
Related Articles
MARKETINGFORCE(02556): Deeply integrate with Ali Qianwen ecosystem, bridge the "last mile" of AI business conversion.
China Great Wall: Basic metal prices fluctuate and adjust to maintain the "stronger than the market" rating of the nonferrous metal industry.
.png)
HK Stock Market Move | XIAOCAIYUAN(00999) rose by over 3% recently, and it plans to establish a joint venture to develop online and community instant food business, aiming to tap into high-quality supply chain resources and growth potential.
MARKETINGFORCE(02556): Deeply integrate with Ali Qianwen ecosystem, bridge the "last mile" of AI business conversion.
China Great Wall: Basic metal prices fluctuate and adjust to maintain the "stronger than the market" rating of the nonferrous metal industry.
HK Stock Market Move | XIAOCAIYUAN(00999) rose by over 3% recently, and it plans to establish a joint venture to develop online and community instant food business, aiming to tap into high-quality supply chain resources and growth potential.
